Department of Haematology Oncology, National University Cancer Institute, Singapore.
Yong Loo Lin School of Medicine, National University of Singapore.
JAMA Netw Open. 2022 Oct 3;5(10):e2237196. doi: 10.1001/jamanetworkopen.2022.37196.
The Cancer and Aging Research Group (CARG) prediction model for chemotherapy-related toxic effects has been developed but not yet validated in older Asian adults. In view of differences in drug metabolism and toxic effect reporting in the Asian population, the ability of this tool to guide the cancer treatment decision-making process in older Asian adults needs to be assessed.
To examine the validity of the CARG predictive model in a multiethnic Asian cohort of older adults.
DESIGN, SETTING, AND PARTICIPANTS: In this prognostic study, patients of various Asian ethnicities 70 years or older with a solid tumor diagnosis receiving chemotherapy at the National University Cancer Institute, Singapore, were accrued from June 1, 2017, to January 1, 2019. Their risks of chemotherapy-related toxic effects were calculated using the CARG tool. A geriatric assessment was performed, and the treating oncologist (blinded to the CARG scores) was asked to give an estimated likelihood of toxic effects (low, medium, or high). Chemotherapy-related toxic effects were recorded during each clinic visit. Validation of the prediction model was performed by calculating the area under the receiver operating characteristic curve. Multivariate analyses were performed to identify variables in other domains in the geriatric assessment predicting for severe toxic effects.
Grade 3 to 5 toxic effects and hospitalization.
The study included 200 patients (median age, 74 years [range, 70-89 years]; 110 [55.0%] male; 177 [88.5%] Chinese, 17 [8.5%] Malay, 4 [2.0%] Indian, and 2 [1.0%] other ethnicities [according to Singapore's national system of race classification]). A total of 137 patients (68.5%) experienced grade 3 to 5 toxic effects, and 131 (65.5%) required hospitalization. The area under the receiver operating characteristic curve for the CARG chemotoxicity prediction model was 0.74 (95% CI, 0.67-0.82), retaining good discrimination in the study population.
This prognostic study conducted in a multiethnic Asian cohort of older adults supports the validity of the CARG predictive model in this population, predicting which older adults are at risk of chemotherapy-related toxic effects.
癌症和衰老研究小组(CARG)预测化疗相关毒性效应的模型已经开发出来,但尚未在亚洲老年人中进行验证。鉴于亚洲人群在药物代谢和毒性效应报告方面存在差异,需要评估该工具在亚洲老年人中指导癌症治疗决策过程的能力。
在一个多民族亚洲老年人群体中检验 CARG 预测模型的有效性。
设计、地点和参与者:在这项预后研究中,2017 年 6 月 1 日至 2019 年 1 月 1 日期间,新加坡国立癌症研究所的各种亚洲种族 70 岁或以上患有实体瘤并接受化疗的患者被纳入研究。使用 CARG 工具计算他们发生化疗相关毒性效应的风险。进行了老年评估,并且要求主治肿瘤学家(对 CARG 评分不知情)估计毒性效应的可能性(低、中或高)。在每次就诊时记录化疗相关的毒性效应。通过计算接受者操作特征曲线下的面积来验证预测模型的有效性。进行了多变量分析,以确定老年评估中其他领域的变量是否可预测严重毒性效应。
3 级至 5 级毒性效应和住院治疗。
该研究纳入了 200 名患者(中位年龄 74 岁[范围 70-89 岁];110 名[55.0%]男性;177 名[88.5%]中国人、17 名[8.5%]马来人、4 名[2.0%]印度人和 2 名[1.0%]其他种族[根据新加坡的国家种族分类系统])。共有 137 名患者(68.5%)发生 3 级至 5 级毒性效应,131 名患者(65.5%)需要住院治疗。CARG 化疗毒性预测模型的受试者工作特征曲线下面积为 0.74(95%CI,0.67-0.82),在研究人群中保持了良好的区分度。
这项在多民族亚洲老年人群体中进行的预后研究支持该预测模型在该人群中的有效性,可预测哪些老年人有发生化疗相关毒性效应的风险。